While the aberrant expression of PD-L1 in multiple cancers enables tumor cells to escape the host immune surveillance and drive tumor metastasis, little is known regarding mechanistic regulation of PD-L1 and PD-1 underlying GBC development. The gene discussed is CD274; the disease is neoplasm.